Medical research

Poxviruses could yield protein pathways for coronavirus vaccine

A vaccine first introduced in the late 1700's could help researchers today looking for a way to fight the coronavirus. Dr. Amy MacNeill, a veterinary pathologist at Colorado State University, and her team are using the vaccinia ...

Health

Could diets that mimic fasting improve people's immune systems?

Professor Valter Longo, director of the USC Longevity Institute, is investigating how fasting and diets that mimic fasting's effects can help immune function, including vaccine efficacy and the body's response to infection ...

Oncology & Cancer

Why throat cancers are on the rise, and why it matters to you

Who among us hasn't had a sore throat, a hoarse voice or a lump in the neck? Usually these are minor problems that go away on their own or after a course of antibiotics—but if they don't, check in with your doctor. These ...

Oncology & Cancer

Prevention and prognosis of cervical cancer

Jiayao Lei's thesis addresses research questions on prevention and prognosis of cervical cancer within the framework of the interplay of human papillomavirus (HPV), vaccination, and cervical screening, and also provides insights ...

page 1 from 30

Cancer vaccine

The term cancer vaccine refers to a vaccine that either prevents infections with cancer-causing viruses, treats existing cancer or prevents the development of cancer in certain high risk individuals.

Some cancers, such as cervical cancer and some liver cancers, are caused by viruses, and traditional vaccines against those viruses, such as HPV vaccine and Hepatitis B vaccine, will prevent those cancers.

Scientists have also been trying to develop vaccines against existing cancers. Some researchers believe that cancer cells routinely arise and are destroyed by the healthy immune system; cancer forms when the immune system fails to destroy them. One approach to cancer vaccination is to separate proteins from cancer cells and immunize cancer patients against those proteins, in the hope of stimulating an immune reaction that would kill the cancer cells. Therapeutic cancer vaccines are being developed for the treatment of breast, lung, colon, skin, kidney, prostate, and other cancers..

On April 14 2009 Dendreon Corporation announced that their Phase III clinical trial of Provenge, a cancer vaccine designed to treat prostate cancer, had succeeded in demonstrating an increase in survival. This is the first robust, statistically significant Phase III result for a cancer vaccine, although the data have yet to be scrutinized by the U.S. Food and Drug Administration or by European Union regulatory agencies. Dendreon is forecasting marketing approval by the FDA by 2010

If Provenge is approved by the FDA, Dendreon will have opened a new era in cancer care.[citation needed]

This text uses material from Wikipedia, licensed under CC BY-SA